Abaxis says FDA approved C-Reactive Protein test for infections and inflammatory diseases
Abaxis says FDA clears new infection test UNION CITY, Calif. — Blood analysis systems company Abaxis Inc. said Thursday it received marketing approval for a test designed to detect infections and inflammatory diseases like rheumatoid arthritis. |